{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:44:52Z","timestamp":1793231092120,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["QPATH4MS"],"award-info":[{"award-number":["QPATH4MS"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.lanepe.2024.100891","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:01:58Z","timestamp":1711756918000},"page":"100891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Consensus quality indicators for monitoring multiple sclerosis"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-8589","authenticated-orcid":false,"given":"Isabel","family":"Voigt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine","family":"Proschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Konofalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Schlieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8799-8202","authenticated-orcid":false,"given":"Tjalf","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2024.100891_bib1","series-title":"Handbook for national quality policy and strategy: a practical approach for developing policy and strategy to improve quality of care","first-page":"86","year":"2018"},{"key":"10.1016\/j.lanepe.2024.100891_bib2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care: how can it Be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2024.100891_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jclinepi.2013.05.018","article-title":"Measuring quality of care: considering measurement frameworks and needs assessment to guide quality indicator development","volume":"66","author":"Stelfox","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100891_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intqhc\/mzg081","article-title":"Defining and classifying clinical indicators for quality improvement","volume":"15","author":"Mainz","year":"2003","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.lanepe.2024.100891_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.708723","article-title":"Quality of care for patients with multiple sclerosis\u2014a review of existing quality indicators","volume":"12","author":"Kraft","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/eurpub\/ckaa165.187","article-title":"The Ipaac evaluation tool: how to select quality indicators for comprehensive cancer care networks","volume":"30","author":"Cocchiara","year":"2020","journal-title":"Eur J Publ Health"},{"key":"10.1016\/j.lanepe.2024.100891_bib7","series-title":"Guidance on developing key performance indicators and minimum data sets to monitor healthcare quality","year":"2013"},{"key":"10.1016\/j.lanepe.2024.100891_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.lanepe.2024.100891_bib9","series-title":"Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie, M\u00fcnchen","year":"2023"},{"key":"10.1016\/j.lanepe.2024.100891_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100891_bib11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1474-4422(18)30248-5","article-title":"Integrating multiple sclerosis guidelines into practice","volume":"17","author":"Macaron","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/jnnp-2022-330169","article-title":"Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study","volume":"94","author":"He","year":"2023","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lanepe.2024.100891_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100891_bib15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","volume":"25","author":"Hobart","year":"2019","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.lanepe.2024.100891_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103358","article-title":"Building a monitoring matrix for the management of multiple sclerosis","volume":"22","author":"Voigt","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lanepe.2024.100891_bib17","series-title":"Quality management systems - EN ISO 9001:2015 for healthcare; German version EN 15224:2016","year":"2017"},{"key":"10.1016\/j.lanepe.2024.100891_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1356436","article-title":"Building digital patient pathways for the management of multiple sclerosis","volume":"15","author":"Wenk","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanepe.2024.100891_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jclinepi.2013.05.017","article-title":"Measuring quality of care: considering conceptual approaches to quality indicator development and evaluation","volume":"66","author":"Stelfox","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100891_bib20","doi-asserted-by":"crossref","first-page":"I39","DOI":"10.1097\/00005650-200301001-00005","article-title":"Selecting common measures of quality and system performance","volume":"41","author":"McGlynn","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.lanepe.2024.100891_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archsurg.2009.291","article-title":"What makes a \u201cgood\u201d quality indicator?: comment on \u201cquality indicators for evaluating trauma care\u201d","volume":"145","author":"Dimick","year":"2010","journal-title":"Arch Surg"},{"key":"10.1016\/j.lanepe.2024.100891_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039770","article-title":"International experiences in the development and implementation of guideline-based quality indicators: a qualitative study","volume":"11","author":"Nothacker","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.lanepe.2024.100891_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.lanepe.2024.100891_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.lanepe.2024.100891_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jclinepi.2014.03.013","article-title":"Scoping reviews: time for clarity in definition, methods, and reporting","volume":"67","author":"Colquhoun","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2024.100891_bib26","series-title":"Understanding patient pathways in the context of integrated health care services-implications from a scoping review. Wirtschaftsinformatik 2019","year":"2019"},{"key":"10.1016\/j.lanepe.2024.100891_bib27","article-title":"Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge","volume":"2013","author":"Baumstarck","year":"2013","journal-title":"Multiple Scler Int"},{"key":"10.1016\/j.lanepe.2024.100891_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.msard.2018.12.021","article-title":"Benefit evaluation in multiple sclerosis relapse treatment from the patients\u2019 perspective - development and validation of a new questionnaire","volume":"28","author":"Beckmann","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.lanepe.2024.100891_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418759189","article-title":"Management of multiple sclerosis patients in central European countries: current needs and potential solutions","volume":"11","author":"Berger","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.lanepe.2024.100891_bib30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1177\/1352458510372394","article-title":"Quality indicators for multiple sclerosis","volume":"16","author":"Cheng","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.lanepe.2024.100891_bib31","first-page":"133","article-title":"OFSEP, a nationwide cohort of people with multiple sclerosis: consensus minimal MRI protocol","volume":"42","author":"Cotton","year":"2015","journal-title":"J\u00a0Neuroradiol"},{"key":"10.1016\/j.lanepe.2024.100891_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1941875210380676","article-title":"A\u00a0proposed roadmap for inpatient neurology quality indicators","volume":"1","author":"Douglas","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.lanepe.2024.100891_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1352458516650741","article-title":"The importance of a multi-disciplinary perspective and patient activation programmes in MS management","volume":"22","author":"Feys","year":"2016","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.lanepe.2024.100891_bib34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.dhjo.2015.02.006","article-title":"Importance of an individual\u2019s evaluation of functional status for health-related quality of life in patients with multiple sclerosis","volume":"8","author":"Gavelova","year":"2015","journal-title":"Disabil Health J"},{"key":"10.1016\/j.lanepe.2024.100891_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.24282","article-title":"Precision medicine in chronic disease management: the multiple sclerosis BioScreen","volume":"76","author":"Gourraud","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2146\/ajhp130495","article-title":"Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis","volume":"71","author":"Hanson","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.lanepe.2024.100891_bib37","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1177\/1352458512445201","article-title":"The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis","volume":"18","author":"Kuspinar","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.lanepe.2024.100891_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.neurol.2015.03.006","article-title":"Targeted clinical audits immediately following the establishment of clinical practice guidelines for multiple sclerosis in 17 neurology departments: a pragmatic and collaborative study","volume":"171","author":"Lairy","year":"2015","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.lanepe.2024.100891_bib39","first-page":"845","article-title":"Incorporating clinical practice guidelines and quality measures into high-quality cost-effective care for patients with multiple sclerosis","volume":"25","author":"Rae-Grant","year":"2019","journal-title":"Continuum"},{"key":"10.1016\/j.lanepe.2024.100891_bib40","first-page":"462","article-title":"Future MS care: a consensus statement of the MS in the 21st century steering group","volume":"260","author":"Rieckmann","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib41","series-title":"Patient experience in adult NHS services","year":"2012"},{"key":"10.1016\/j.lanepe.2024.100891_bib42","series-title":"Multiple sclerosis","year":"2016"},{"key":"10.1016\/j.lanepe.2024.100891_bib43","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1212\/WNL.0000000000001965","article-title":"Quality improvement in neurology: multiple sclerosis quality measures: executive summary","volume":"85","author":"Rae-Grant","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100891_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000012124","article-title":"Quality improvement in neurology. Multiple sclerosis quality measurement set 2020 update","volume":"97","author":"Rae-Grant","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100891_bib45","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","first-page":"301","article-title":"Diagnose und therapie der multiplen sklerose, neuromyelitis-opticaSpektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen","author":"Hemmer","year":"2021"},{"key":"10.1016\/j.lanepe.2024.100891_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211039648","article-title":"Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)","volume":"14","author":"Wiendl","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.lanepe.2024.100891_bib47","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.lanepe.2024.100891_bib48","series-title":"Crossing the quality chasm: a new health system for the 21st century","year":"2001"},{"key":"10.1016\/j.lanepe.2024.100891_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/intqhc\/mzn048","article-title":"A\u00a0quality management model for integrated care: results of a Delphi and Concept Mapping study","volume":"21","author":"Minkman","year":"2009","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.lanepe.2024.100891_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10755-006-9022-8","article-title":"Idea generation and exploration: benefits and limitations of the policy Delphi research method","volume":"31","author":"Franklin","year":"2007","journal-title":"Innovat High Educ"},{"key":"10.1016\/j.lanepe.2024.100891_bib51","first-page":"683","article-title":"QUALIFY: ein Instrument zur Bewertung von Qualit\u00e4tsindikatoren","volume":"101","author":"Reiter","year":"2008","journal-title":"Zeitschrift f\u00fcr \u00e4rztliche Fortbildung und Qualit\u00e4t im Gesundheitswesen - German J Qual Health Care"},{"key":"10.1016\/j.lanepe.2024.100891_bib52","series-title":"The RAND\/UCLA appropriateness method user\u2019s manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.lanepe.2024.100891_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzab107","article-title":"What makes a good quality indicator set? A systematic review of criteria","volume":"33","author":"Schang","year":"2021","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.lanepe.2024.100891_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1352458513503392","article-title":"Multiple sclerosis outcome assessments consortium: genesis and initial project plan","volume":"20","author":"Rudick","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.lanepe.2024.100891_bib56","article-title":"The multiple sclerosis performance test (MSPT): an iPad-based disability assessment tool","volume":"88","author":"Rudick","year":"2014","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.lanepe.2024.100891_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/brainsci11081049","article-title":"Using machine learning algorithms for identifying gait parameters suitable to evaluate subtle changes in gait in people with multiple sclerosis","volume":"11","author":"Trentzsch","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.lanepe.2024.100891_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.60.1.31","article-title":"Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)","volume":"60","author":"Hobart","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lanepe.2024.100891_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/brain\/awh675","article-title":"Getting the measure of spasticity in multiple sclerosis: the multiple sclerosis spasticity scale (MSSS-88)","volume":"129","author":"Hobart","year":"2006","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.lanepe.2024.100891_bib60","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.clineuro.2013.09.022","article-title":"Perspectives of an innovative ophthalmological technology: optical coherence tomography (OCT)--what should be of interest to the neurologist?","volume":"115","author":"Ziemssen","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.lanepe.2024.100891_bib61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458511431076","article-title":"Recommendations for a Brief international cognitive assessment for multiple sclerosis (BICAMS)","volume":"18","author":"Langdon","year":"2012","journal-title":"Multiple Scler J"},{"key":"10.1016\/j.lanepe.2024.100891_bib62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1355617706060723","article-title":"Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)","volume":"12","author":"Benedict","year":"2006","journal-title":"J\u00a0Int Neuropsychol Soc"},{"key":"10.1016\/j.lanepe.2024.100891_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.gtc.2013.05.005","article-title":"Colonoscopy quality: metrics and implementation","volume":"42","author":"Calderwood","year":"2013","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.lanepe.2024.100891_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109589","article-title":"ESGO\/ESTRO quality indicators for radiation therapy of cervical cancer","volume":"183","author":"Chargari","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.lanepe.2024.100891_bib65","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.14309\/ajg.0000000000001903","article-title":"Quality indicators for capsule endoscopy and deep enteroscopy","volume":"117","author":"Leighton","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.lanepe.2024.100891_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1155\/2014\/941245","article-title":"Defining quality indicators for best-practice management of inflammatory bowel disease in Canada","volume":"28","author":"Nguyen","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.lanepe.2024.100891_bib67","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2471\/BLT.20.251405","article-title":"Development and implementation of guidelines for the management of depression: a systematic review","volume":"98","author":"Lee","year":"2020","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanepe.2024.100891_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40900-022-00397-z","article-title":"Co-designing person-centred quality indicator implementation for primary care in Alberta: a consensus study","volume":"8","author":"Manalili","year":"2022","journal-title":"Res Involv Engagem"},{"key":"10.1016\/j.lanepe.2024.100891_bib69","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00101-020-00773-y","article-title":"Implementation of anesthesia quality indicators in Germany : a prospective, national, multicenter quality improvement study","volume":"70","author":"Ziemann","year":"2021","journal-title":"Der Anaesthesist"},{"key":"10.1016\/j.lanepe.2024.100891_bib70","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10072-011-0776-0","article-title":"The\u00a0importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of\u00a0multiple sclerosis patients with mild and moderate disability","volume":"33","author":"Koudriavtseva","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.lanepe.2024.100891_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1748-5908-7-21","article-title":"Methods for the guideline-based development of quality indicators--a systematic review","volume":"7","author":"K\u00f6tter","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.lanepe.2024.100891_bib72","series-title":"Improving patient care: the implementation of\u00a0change in health care","first-page":"40","article-title":"Effective implementation of change in healthcare: a systematic approach","author":"Grol","year":"2013"},{"key":"10.1016\/j.lanepe.2024.100891_bib73","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3390\/brainsci11111519","article-title":"Digital biomarkers in multiple sclerosis","volume":"11","author":"Dillenseger","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.lanepe.2024.100891_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669811","article-title":"Digital twins for multiple sclerosis","volume":"12","author":"Voigt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanepe.2024.100891_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41582-020-00448-7","article-title":"Standardization and digitization of clinical data in multiple sclerosis","volume":"17","author":"D'Souza","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.lanepe.2024.100891_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102512","article-title":"Clinical outcome measures in multiple sclerosis: a review","volume":"19","author":"Inojosa","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lanepe.2024.100891_bib77","series-title":"Digital healthcare research: plan-do-check-act cycle","year":"2023"},{"key":"10.1016\/j.lanepe.2024.100891_bib78","article-title":"Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis","volume":"29","author":"He","year":"2023","journal-title":"Multiple Scler J"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776224000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T05:29:04Z","timestamp":1717910944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776224000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":77,"alternative-id":["S2666776224000577"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100891","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus quality indicators for monitoring multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2024.100891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100891"}}